Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-05

Clinical Trial Update: Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated low-dose ketamine infusions in adolescents with treatment-resistant depression and major depressive disorder. The study status is list…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Treatment-resistant Depression, Major Depressive Disorder | Phase 4 | Status: COMPLETED